BIOXCEL THERAPEU

BTAI NASDAQ
10.80
-0.14
-1.28%
交易中 14:11 06/25 EDT
开盘
11.31
昨收
10.94
最高
11.31
最低
10.64
成交量
3.10万
成交均量(3M)
3.49万
52周最高
14.79
52周最低
2.410
换手率
0.20%
市值
1.69亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供BIOXCEL THERAPEU BTAI股票价格,BIOXCEL THERAPEU股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers. The Company uses novel artificial intelligence (AI) for drug re-innovation processes of approved product candidates to identify new therapeutic indices. Its principal clinical development programs are BXCL501 and BXCL701. BXCL501 is a sublingual thin film formulation of dexmedetomidine (Dex) designed for the acute treatment of agitation resulting from neurological and psychiatric disorders. BXCL701 is an immuno-oncology agent designed for the treatment of prostate and pancreatic cancer.
展开 >

最近浏览

名称
价格
涨跌幅